Member Comments are provided by individuals and reflect their personal opinions only. Under NO circumstances should you act on any advice or opinion posted in this forum. ALWAYS check with your personal physician before taking any action regarding your health! MedHelp International and our partners, sponsors and affiliates have no obligation to monitor any comments posted on this site, or the content and/or accuracy of such exchanges. MedHelp International does not endorse the views of any user.
This patient support community is for discussions relating to women's health issues, bone health, cancers, genetic testing, heart, infectious diseases, work issues, mammograms, reproductive health, sexuality, and sexual violence.
Hi Anne, I'm 60 and I had a complete hysterectomy at age 44. I've been on Estratest ever since and started taking half the dose about 6 months ago without any side affects. It has just started since I started taking the Nexium.
The safety of NEXIUM was evaluated in over 15,000 patients (aged 18-84 years) in clinical trials worldwide including over 8,500 patients in the United States and over 6,500 patients in Europe and Canada. Over 2,900 patients were treated in long-term studies for up to 6-12 months. In general, NEXIUM was well tolerated in both short and long-term clinical trials.
.
Additional adverse events that were reported as possibly or probably related to NEXIUM with an incidence < 1% are listed below by body system:
The safety of NEXIUM was evaluated in over 15,000 patients (aged 18-84 years) in clinical trials worldwide including over 8,500 patients in the United States and over 6,500 patients in Europe and Canada. Over 2,900 patients were treated in long-term studies for up to 6-12 months. In general, NEXIUM was well tolerated in both short and long-term clinical trials.
.
Additional adverse events that were reported as possibly or probably related to NEXIUM with an incidence < 1% are listed below by body system:
The safety of NEXIUM was evaluated in over 15,000 patients (aged 18-84 years) in clinical trials worldwide including over 8,500 patients in the United States and over 6,500 patients in Europe and Canada. Over 2,900 patients were treated in long-term studies for up to 6-12 months. In general, NEXIUM was well tolerated in both short and long-term clinical trials.
.
Additional adverse events that were reported as possibly or probably related to NEXIUM with an incidence < 1% are listed below by body system:
http://www.rxlist.com/cgi/generic/esomeprazole_ad.htm
The safety of NEXIUM was evaluated in over 15,000 patients (aged 18-84 years) in clinical trials worldwide including over 8,500 patients in the United States and over 6,500 patients in Europe and Canada. Over 2,900 patients were treated in long-term studies for up to 6-12 months. In general, NEXIUM was well tolerated in both short and long-term clinical trials.
.
Additional adverse events that were reported as possibly or probably related to NEXIUM with an incidence < 1% are listed below by body system:
http://www.rxlist.com/cgi/generic/esomeprazole_ad.htm